Federal jurors in Chicago say the pharmaceutical company AbbVie should pay $150 million to an Oregon man for misrepresenting the risks of a low testosterone treatment. The Chicago Tribune reports that the jury arrived at the figure for punitive damages …
from News – Insurance Journal http://ift.tt/2uBTpAX
via
IFTTT
No comments:
Post a Comment